Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

NCT00509873 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00509873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00509873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2007
Completion date
June 30, 2008
Enrollment
578 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial conjunctivitis